Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for NTRB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
July 31, 2026 40.73%
April 30, 2026 44.53%
January 31, 2026 17.02%
October 31, 2025 18.20%
July 31, 2025 23.86%
April 30, 2025 36.48%
January 31, 2025 42.75%
October 31, 2024 27.81%
July 31, 2024 20.51%
April 30, 2024 37.75%
January 31, 2024 32.44%
October 31, 2023 34.64%
July 31, 2023 44.05%
April 30, 2023 44.35%
January 31, 2023 24.53%
October 31, 2022 43.48%
Date Value
July 31, 2022 33.28%
April 30, 2022 41.95%
January 31, 2022 21.00%
October 31, 2021 38.62%
July 31, 2021 12.63%
April 30, 2021 54.88%
January 31, 2021 53.55%
October 31, 2020 41.60%
July 31, 2020 -38.51%
April 30, 2020 37.19%
January 31, 2020 -544.4%
October 31, 2019 -28.57%
July 31, 2019 -57.41%
April 30, 2019 -2.69%
January 31, 2019 0.61%
October 31, 2018 -26.72%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 54.97%
Corcept Therapeutics, Inc. 98.41%
Veru, Inc. --
Johnson & Johnson 68.73%
Eli Lilly & Co. 85.78%

Gross Profit Margin (Quarterly) Related Metrics